Axsome Therapeutics reported cash from operations of -$32.95M and free cash flow of -$33.40M for the quarter ended Jun 2026, down 1.6% year over year. This cash flow statement covers 46 quarters of results from Mar 2015 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Cash Flow Statement | Mar2015 | Jun2015 | Sep2015 | Dec2015 | Mar2016 | Jun2016 | Sep2016 | Dec2016 | Mar2017 | Jun2017 | Sep2017 | Dec2017 | Mar2018 | Jun2018 | Sep2018 | Dec2018 | Mar2019 | Jun2019 | Sep2019 | Dec2019 | Mar2020 | Jun2020 | Sep2020 | Dec2020 | Mar2021 | Jun2021 | Sep2021 | Dec2021 | Mar2022 | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||||||||||||||||||||||||||||||||||||||||
| Net Income | -34.88M | -33.98M | -39.63M | -41.44M | -44.82M | -61.24M | -11.24M | -67.17M | -62.18M | -98.64M | -68.36M | -79.34M | -64.60M | -74.91M | -59.41M | -47.93M | -47.23M | 9.35M | -64.54M | -51.31M | ||||||||||||||||||||||||||
| Share-based CompensationStock Comp. | 5.73M | 5.89M | 7.60M | 6.52M | 6.54M | 10.77M | 12.94M | 15.92M | 16.37M | 18.91M | 20.19M | 21.38M | 21.66M | 21.99M | 23.87M | 24.61M | 23.10M | 22.73M | 82.80M | 68.30M | ||||||||||||||||||||||||||
| Gains from Investment SecuritiesGains Investment | ||||||||||||||||||||||||||||||||||||||||||||||
| Cash from OperationsCash from Ops. | -26.78M | -28.84M | -32.65M | -33.54M | -22.76M | -27.56M | -5.82M | -55.35M | -53.55M | -30.36M | -53.47M | -30.11M | -18.63M | -26.20M | -43.38M | -32.42M | 1.05M | -18.65M | -20.70M | -32.95M | ||||||||||||||||||||||||||
| Depreciation, Depletion & Amortization | ||||||||||||||||||||||||||||||||||||||||||||||
| Amortizatization of IntangiblesAmort. of Intangibles | 0.14M | 0.23M | 0.28M | 0.30M | 0.25M | 0.35M | 0.58M | 0.64M | 0.29M | 0.45M | 0.62M | 0.26M | 0.32M | 0.71M | 0.67M | 0.54M | 0.68M | 0.55M | 0.68M | 1.16M | ||||||||||||||||||||||||||
| Amortization of Deferred ChargesAmort. Deferred Charges | ||||||||||||||||||||||||||||||||||||||||||||||
| Change in Working Capital | ||||||||||||||||||||||||||||||||||||||||||||||
| Change in ReceivablesChange Receivables | 4.13M | 17.40M | 7.09M | 22.62M | 11.01M | 16.41M | 6.62M | 18.91M | 3.75M | 17.91M | 19.40M | 37.43M | -2.32M | 27.96M | 26.60M | 26.40M | ||||||||||||||||||||||||||||||
| Change in InventoryChange Inventory | 0.29M | 1.32M | 3.62M | 1.31M | -1.66M | 4.89M | 0.10M | -0.69M | -1.29M | 1.13M | 0.25M | 1.78M | 4.99M | 3.64M | 3.11M | 5.89M | ||||||||||||||||||||||||||||||
| Change in Account PayablesChange Payables | 1.77M | -0.23M | -0.55M | 6.84M | -6.59M | 25.76M | -2.83M | 7.19M | -13.86M | 11.58M | 13.11M | 7.55M | 2.91M | 7.74M | 13.66M | 5.97M | -37.40M | 11.31M | 41.16M | -27.73M | ||||||||||||||||||||||||||
| Change in Accured ExpensesChange Accured Exp. | 0.28M | -1.15M | 1.69M | 5.49M | 23.54M | 13.20M | 7.14M | 3.96M | 13.98M | 11.36M | -8.41M | 33.49M | 5.32M | 25.67M | 0.82M | 21.50M | 54.25M | 7.17M | 17.23M | 46.61M | ||||||||||||||||||||||||||
| Investing Activities | ||||||||||||||||||||||||||||||||||||||||||||||
| Capital ExpendituresCapex | 0.26M | 451.00 | 0.21M | 0.24M | 0.07M | 0.18M | 0.07M | 0.13M | 0.37M | 0.01M | 0.10M | 0.05M | 0.09M | 0.03M | 0.34M | 0.01M | 0.06M | 0.07M | 0.12M | 0.45M | ||||||||||||||||||||||||||
| Cash from Investing ActivitiesCash from Investing | -0.26M | -451.00 | -0.21M | -53.24M | -0.07M | -0.18M | -0.07M | -0.13M | -0.37M | -0.01M | -0.10M | -0.05M | -0.09M | -0.03M | -0.34M | -0.01M | -0.06M | -0.07M | -0.12M | -0.45M | ||||||||||||||||||||||||||
| Financing Activities | ||||||||||||||||||||||||||||||||||||||||||||||
| Other financing activitiesOther financing | 0.44M | 1.09M | 0.18M | 0.18M | 3.06M | 2.83M | 0.39M | 6.57M | 4.32M | 1.15M | 2.50M | 17.04M | ||||||||||||||||||||||||||||||||||
| Cash from Financing ActivitiesCash from Financing | 0.44M | 0.69M | 31.10M | 75.46M | 176.95M | 1.07M | 51.56M | 246.08M | 33.37M | -0.00M | -1.19M | 14.38M | 30.41M | 14.24M | 29.27M | 34.54M | 21.27M | 16.39M | 2.99M | 48.15M | ||||||||||||||||||||||||||
| Change in Capital Stock | ||||||||||||||||||||||||||||||||||||||||||||||
| Net Shares Issued and RepurchasedNet Shares Issued | 2.04M | 1.22M | 2.22M | 1.54M | 2.53M | 0.90M | 1.22M | 0.27M | 0.39M | 0.02M | ||||||||||||||||||||||||||||||||||||
| Net Equity Issued and RepurchasedNet Equity Issued | 0.22M | 31.01M | 32.55M | 180.20M | 211.30M | 33.75M | 13.10M | 16.42M | 19.65M | 32.63M | 9.95M | 5.67M | 6.34M | 13.47M | ||||||||||||||||||||||||||||||||
| Additional items | ||||||||||||||||||||||||||||||||||||||||||||||
| Change in Cash | -26.60M | -28.15M | -1.76M | -11.31M | 154.13M | -26.68M | 45.67M | 190.60M | -20.55M | -30.37M | -54.75M | -15.78M | 11.68M | -11.99M | -14.44M | 2.11M | 22.26M | -2.34M | -17.83M | 14.74M | ||||||||||||||||||||||||||
| Free Cash FlowFCF | -27.03M | -28.84M | -32.87M | -33.78M | -22.82M | -27.74M | -5.89M | -55.48M | -53.92M | -30.37M | -53.56M | -30.16M | -18.72M | -26.23M | -43.71M | -32.44M | 0.99M | -18.72M | -20.82M | -33.40M | ||||||||||||||||||||||||||
| Net Cash FlowNCF | -26.60M | -28.15M | -1.76M | -11.31M | 154.13M | -26.68M | 45.67M | 190.60M | -20.55M | -30.37M | -54.75M | -15.78M | 11.68M | -11.99M | -14.44M | 2.11M | 22.26M | -2.34M | -17.83M | 14.74M |